Abstract

The last decade has seen an increasing awareness for patients with connective disorders and patients with Marfan syndrome (MFS) in particular. MFS has long been the only seriously considered differential diagnosis in young patients presenting with aortic aneurysms. The advent of multi-gene panel genetic testing and the discovery of new syndromic forms of connective tissue disorders such as Loeys-Dietz syndrome (LDS) as well as many forms of non-syndromic presentations have established thoracic aortic aneurysms as a genetically mediated disease. Although the spectrum has broadened, MFS still serves as a model for connective tissue disorders with vascular involvement. The vast majority of MFS patients develop aortic root aneurysms over time. Most MFS patients undergo root surgery in their early 30s. As patients with LDS patients may dissect below the accepted threshold for surgery in MFS patients, earlier intervention is recommended. The need for re-intervention in these patients is driven by a history of aortic dissection and prevention of dissection is of paramount importance.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call